Cargando...
Desvenlafaxine and Weight Change in Major Depressive Disorder
OBJECTIVE: To characterize weight change during short- and longer-term treatment with desvenlafaxine (administered as desvenlafaxine succinate) for major depressive disorder (MDD). METHOD: Data from 9 short-term, double-blind, placebo-controlled studies and 1 longer-term relapse-prevention trial con...
Gardado en:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Physicians Postgraduate Press, Inc.
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2882808/ https://ncbi.nlm.nih.gov/pubmed/20582292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.08m00746blu |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|